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Abstract 49 
The laboratory mouse is the most widely used animal model for biomedical research, due in 50 
part to its well annotated genome, wealth of genetic resources and the ability to precisely 51 
manipulate its genome. Despite the importance of genetics for mouse research, genetic quality 52 
control (QC) is not standardized, in part due to the lack of cost effective, informative and robust 53 
platforms. Genotyping arrays are standard tools for mouse research and remain an attractive 54 
alternative even in the era of high-throughput whole genome sequencing. Here we describe the 55 
content and performance of a new Mouse Universal Genotyping Array (MUGA). MiniMUGA, an 56 
array-based genetic QC platform with over 11,000 probes. In addition to robust discrimination 57 
between most classical and wild-derived laboratory strains, MiniMUGA was designed to contain 58 
features not available in other platforms: 1) chromosomal sex determination, 2) discrimination 59 
between substrains from multiple commercial vendors, 3) diagnostic SNPs for popular 60 
laboratory strains, 4) detection of constructs used in genetically engineered mice, and 5) an 61 
easy to interpret report summarizing these results. In-depth annotation of all probes should 62 
facilitate custom analyses by individual researchers. To determine the performance of 63 
MiniMUGA we genotyped 6,899 samples from a wide variety of genetic backgrounds. The 64 
performance of MiniMUGA compares favorably with three previous iterations of the MUGA 65 
family of arrays both in discrimination capabilities and robustness. We have generated publicly 66 
available consensus genotypes for 241 inbred strains including classical, wild-derived and 67 
recombinant inbred lines. Here we also report the detection of a substantial number of XO and 68 
XXY individuals across a variety of sample types, the extension of the utility of reduced 69 
complexity crosses to genetic backgrounds other than C57BL/6, and the robust detection of 17 70 
genetic constructs. There is preliminary but striking evidence that the array can be used to 71 
identify both partial sex chromosome duplication and mosaicism, and that diagnostic SNPs can 72 
be used to determine how long inbred mice have been bred independently from the main stock  73 
for a significant action of the genotyped inbred samples. We conclude that MiniMUGA is a 74 
valuable platform for genetic QC and important new tool to the increase rigor and 75 
reproducibility of mouse research. 76 
 77 
  78 
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INTRODUCTION 79 
The laboratory mouse is among the most popular and extensively used platforms for 80 
biomedical research.  For example, in 2018 over 82,000 scientific manuscripts available in 81 
PubMed included the word “mouse” in the abstract.  The laboratory mouse is such an attractive 82 
model due to the existence of hundreds of inbred strains and outbred lines designed to address 83 
specific questions, as well as the ability to edit the mouse genome; originally by homologous 84 
recombination and now with more efficient and simple techniques such as CRISPR (Dong et al. 85 
2019; Ayabe et al. 2019).  The centrality of genetics in mouse-enabled research begs the 86 
question of how genetic quality control (QC) is performed in these experiments. 87 
We have a long track record of developing genotyping arrays for the laboratory mouse, from 88 
the Mouse Diversity Array (Yang et al. 2009) to the previous versions versions of the Mouse 89 
Universal Genotyping Array (MUGA,(Morgan et al. 2015)).  These tools were originally designed 90 
for the genetic characterization of two popular genetic reference populations, the Collaborative 91 
Cross (CC) and the Diversity Outbred (DO), and then used for many other laboratory strains as 92 
well as wild mice (Yang et al. 2011; Collaborative Cross Consortium 2012; Carbonetto et al. 93 
2014; Arends et al. 2016; Didion et al. 2016; Shorter et al. 2017; Srivastava et al. 2017; Rosshart 94 
et al. 2017; Veale et al. 2018).  Efforts to extend the use of MUGA to characterize copy number 95 
variation and genetic constructs were met with limited success (Morgan et al. 2015).  In 96 
conclusion, current genotyping tools are suboptimal for genetic QC and for new experimental 97 
designs aimed at facilitating the rapid identification of causal genetic variants in mouse crosses.   98 
An improved genotyping platform would ideally be able to provide reliable information about 99 
the sex, genetic background and presence of genetic constructs in a given sample in a robust 100 
and cost-effective manner.  The ability to discriminate between most genetic backgrounds is 101 
critical for genetic QC.  The success of a new genotyping platform depends on how it compares 102 
to other more comprehensive solutions such as whole genome sequence (WGS) in terms of 103 
cost and ease involved in generating, analyzing, and interpreting the data.  This is important 104 
because many analyses require more sophisticated approaches and skills that are beyond many 105 
users of laboratory mice.  In addition, a new platform is needed to extend the success of 106 
reduced complexity crosses (RCC) beyond the C57BL/6J – C57BL/6NJ pair of strains (Kumar et 107 
al. 2013; Babbs et al. 2019).  RCC are predicated on the idea that if a genetically driven 108 
phenotype is variable between a pair of closely related laboratory substrains, then QTL 109 
mapping combined with a complete catalog of the few thousand variants that differ among 110 
these substrains can lead to the rapid identification of the candidate causal variants (Kumar et 111 
al. 2013).  This addresses one of the major limitations of standard mouse crosses, namely the 112 
cost in time and resources to move from QTL to quantitative trait variants (QTV).  Genetic 113 
mapping in experimental F2 populations requires assigning every genomic region to one of 114 
three diplotypes based on their genotypes at segregating SNPs or other variants.  The difficulty 115 
in RCC is two fold: first, genetic variants are unknown because WGS is not publicly available for 116 
most substrains; second, these variants are so rare (5-20K genome wide or one variant per 100 117 
to 500 kb) that low pass WGS will miss the majority of them, complicating the analysis.  In other 118 
words, the feature that makes RCC attractive for rapid QTV identification also makes it very 119 
difficult to implement. 120 
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To address these issues we created a fourth iteration of the MUGA family of arrays that we call 121 
MiniMUGA.  The central considerations for the design were to reduce genotyping costs, provide 122 
broad discrimination between most inbred strains, support genetic mapping in dozens of 123 
different RCCs involving multiple substrains available from commercial vendors, robustly 124 
determine chromosomal sex, and reliably detect presence of popular genetic constructs.  125 
MiniMUGA fulfills all these criteria and facilitates simple, uniform and cost effective standard 126 
genetic QC, as well as serving the mouse community at large by providing a new tool for genetic 127 
studies. 128 
 129 
MATERIALS AND METHODS 130 
Reference samples 131 
A diverse panel of 6,899 samples was used for calibrating and evaluating the performance of 132 
the array.  The type of sample is provided in Table 1.  To test the performance of each 133 
individual marker, provide reliable consensus genotypes and asses diagnostic markers, several 134 
biological and/or technical replicates for many inbred strains and F1 hybrids were included.  135 
Supplementary Table 1 provides comprehensive information about each of these samples 136 
including sample name, type, whether it was genotyped in the initial or final version of the 137 
array, whether the sample was used to determine consensus genotypes or thresholds for 138 
chromosomal sex, chromosomal sex, basic QC metrics and values used to determine the 139 
presence of 17 constructs. A complete description of the information provided in 140 
Supplementary Table 1 is available in the table legend. 141 
DNA stocks for classical inbred strains were purchased from The Jackson Laboratory or provided 142 
by the authors. DNA from most other samples was prepared from tail clips or spleens using the 143 
DNeasy Blood & Tissue Kit (catalog no. 69506; Qiagen, Hilden, Germany).  144 
Microarray platform 145 
MiniMUGA is implemented on the Illumina Infinium HD platform (Steemers et al. 2006). 146 
Invariable oligonucleotide probes 50 bp in length are conjugated to silica beads that are then 147 
addressed to wells on a chip. Sample DNA is hybridized to the oligonucleotide probes and a 148 
single-basepair templated-extension reaction is performed with fluorescently labeled 149 
nucleotides. The relative signal intensity from alternate fluorophores at the target nucleotide is 150 
processed into a discrete genotype call (AA, AB, BB) using the Illumina BeadStudio software.  151 
Although the two-color Infinium readout is optimized for genotyping biallelic SNPs, both total 152 
and relative signal intensity can also be informative for copy-number variation and construct 153 
detection. 154 
Probe design 155 
Of the 11,125 markers present in the array, 10,819 (97.2%) are probes designed for biallelic 156 
SNPs and the remaining 306 markers (2.6%) are probes designed to test the presence of genetic 157 
constructs (Supplementary Table 2).  Nucleotides are labeled such that only one silica bead is 158 
required to genotype most SNPs, except the cases of [A/T] and [C/G] SNPs, which require two 159 
beads. In order to maximize information content, target SNPs were biased toward single-bead 160 
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SNPs (mostly transitions). There are 10,721 single-bead assays and 404 two bead assays.  The 161 
transition:transversion ratio in SNPs (excluding constructs) is 3:1. 162 
Array hybridization and genotype calling 163 
Approximately 1.5 g genomic DNA per sample was shipped to Neogen Inc. (Lincoln, NE) for 164 
array hybridization. Genotypes were called jointly for all reference samples using the GenCall 165 
algorithm implemented in the Illumina BeadStudio software. 166 
Probe Annotation 167 
Probe design and performance of individual assays was used to annotate the array. 168 
Supplementary Table 2 provides a rich set of annotations for each marker including: marker 169 
name, chromosome position, strand, probe sequence, performance, rsID, diagnostic value, 170 
thresholds for construct probes. A complete description of the information provided in 171 
Supplementary Table 2 is available in the table legend. 172 
Chromosomal sex determination 173 
We selected a set of 2,348 control samples (1,108 males and 1,240 females) with known X and 174 
Y chromosome number as determined through standard phenotypical sexing, which was 175 
supported by genotype analysis when expected heterozygosity on chromosome X was known. 176 
For each control sample, we first normalized the intensity values at each X and Y chromosome 177 
marker by dividing the intensity (r) by the sample’s median autosomal intensity. These 178 
autosome-normalized intensity values are used in all subsequent sex-determination 179 
calculations. 180 
The first step of chromosomal sex determination was to identify sex-linked markers that 181 
provide a consistent estimate of of sex chromosome number with minimal noise. We identified 182 
269 X and 72 Y sex-informative markers as those for which the ranges of median normalized 183 
intensity as defined by their standard deviations do not overlap between male and female 184 
controls (Supplemental Figure 1). This information is provided in Supplementary Table 2. 185 
Next, we established chromosomal sex intensity threshold values. For each sample, we plotted 186 
the median of the normalized intensity values at the X informative markers on the x axis and 187 
median of the normalized intensity values at the Y informative markers on the y axis (Figure 1). 188 
Based on this plot we identified four clusters in sample intensity that correspond to XX, XY, XO, 189 
and XXY chromosomal sex. We defined thresholds as the midpoint between the relevant 190 
clusters. There is a single Y threshold value (0.3), separating samples with or without a Y 191 
chromosome. We identified two independent X threshold values (0.77 and 0.69) depending on 192 
whether the sample has a Y chromosome or not.  These threshold values were used to classify 193 
the chromosomal sex of experimental samples into four groups, XX, XY, XO, or XXY.  194 
Generation of consensus genotypes 195 
The impetus for creating consensus genotypes for inbred strains in MiniMUGA is to provide a 196 
set of reference genotype calls for widely used strains. When possible, we included multiple 197 
biological and technical replicates of a given inbred strain to smooth over any errors in 198 
genotyping results, identify problematic markers, and to provide a more robust set of reference 199 
calls for comparison.  200 
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For each of 241 inbred strains (Supplementary Table 3), we genotyped from 1 to 19 samples 201 
(average 3.2 per strain).  Most inbred strains (179) were genotyped more than once.  For 53 202 
strains (mostly BXD recombinant inbred lines) we did not genotype a male animal and thus Y 203 
chromosome genotypes are not provided for those strains. Over half of the strains (146) were 204 
genotyped only in the initial version of the array, so final content genotypes are missing in 205 
those strains. See Supplementary Table 1 for details. 206 
We generated consensus genotype calls at all 10,819 of the autosomal, X, pseudo-autosomal 207 
region (PAR), and Y chromosome markers (biallelic SNPs).  For each consensus strain, at each 208 
marker, we recorded the genotype calls in all of the constituent samples and determined the 209 
consistency among these calls.  For strains with more than one sample, if all calls are consistent, 210 
the consensus genotype is shown in upper case (A,T,C,G,H,N). Partially consistent calls are 211 
those with a mix of one or more calls of a single nucleotide and one or more H and/or N calls. 212 
Partially consistent calls are shown in lower case, as are calls for strains with a single 213 
constituent sample.  Inconsistent calls are those for which two distinct nucleotides calls are 214 
observed.  For standard markers, inconsistent genotypes within a strain are is shown as N in the 215 
consensus.  For partially diagnostic SNPs the consensus call is the diagnostic allele shown in 216 
lower case. For CC strains, inconsistent consensus genotypes are shown as H, as these markers 217 
can be heterozygous in such samples. For mitochondria and Y chromosome markers, consensus 218 
calls follow the same rules except H calls are treated as N.  Supplementary Table 4 provides a 219 
list of rules for generating all possible consensus calls. Supplementary Table 5 provides a listing 220 
of the consensus genotypes. 221 
Informative SNPs between closely related substrains 222 
To increase the specificity of MiniMUGA as a tool for discriminating between closely related 223 
inbred strains, we used public data from several other studies providing genotype or whole-224 
genome sequence information (Yang et al. 2009; Keane et al. 2011; Adams et al. 2015; Morgan 225 
et al. 2015). Most importantly, we included SNP variants that are segregating between 226 
substrains. These SNPs were identified by whole genome sequencing of 33 substrains 227 
performed as part of two ongoing collaborations (contributed by either MTF, RSB and MTH, or 228 
MTF and CMS; Table 2).  Finally, we included 339 variants discriminating substrains of C57BL/10 229 
(provided by AAP, YR and CSP). Some of the 5,171 GigaMUGA probes included to cover the 230 
genome uniformly in classical and wild-derived inbred strains were also informative for 231 
substrains. 232 
Probes for genetically engineered constructs   233 
We selected 36 constructs commonly used in genetic engineering in the mouse. For each 234 
construct, we obtained full length sequence from either Addgene or GenBank. We ran a BLAST 235 
search (Johnson et al. 2008) on these sequences to identify 2-5 additional sequences which (a) 236 
had high BLAST scores, and (b) were annotated as containing the relevant construct gene we 237 
were searching for (all sequence accession numbers are in Supplementary Table 8). For each 238 
construct, sequences were then aligned using the EMBOSS Water algorithm from EMBL-EBI  239 
(https://www.ebi.ac.uk/Tools/psa/emboss_water/). We identified conserved 50-mers within 240 
these alignments followed by a single A in the forward strand, or followed by a single T in the 241 
reverse strand. These sequences were submitted to the Illumina BeadStudio design pipeline, 242 
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with a pseudo-SNP (A/G or T/C). Probes which passed a quality score threshold of 0.7 were 243 
included in the array. In total we created 306 probes for these constructs (range 3-18, median 8 244 
probes/construct). 245 
 246 
In order to validate these probes, we first eliminated probes which had high intensity signal in 247 
the 580 negative control samples (standard inbred mouse strains and F1 hybrids between 248 
them). Next, among the remaining probes, we identified those with significantly variable 249 
intensity among the remaining 6,319 samples in this study. In particular, we confirmed that, 250 
where available, positive controls had high signal intensity.  251 
This process left 163 validated probes. We noticed that signal intensity of validated probes was 252 
often positively correlated with other validated probes with the same, or related target 253 
constructs. All validated probes were then subject to a second round of BLAST for final 254 
identification of the targeted constructs and to provide a biological basis for grouping of highly 255 
correlated probes.  These alignments are provided in Supplementary Figure 2. In total these 256 
163 probes mapped to 17 biologically distinct constructs (see Table 3).  Probes tracking the 257 
hCMV enhancer can divided into two groups based on the clustering. 258 
Once we selected the final set of validated probes for a specific construct, we used the per-259 
sample distribution of the sum validated probe intensity to manually identify conservative 260 
threshold values for the presence and absence of each construct. We used the negative and 261 
positive controls to set initial thresholds and then used the distribution of values to identify 262 
breaks and set the final thresholds such that we minimize the number of samples misclassified 263 
as positive or negative. 264 
 265 
Additional sample quality metrics 266 
Most quality metrics for genotyping arrays are based on genotype calls. However, intensity 267 
based analyses, such as chromosomal sex determination, assume quasi-normal distribution of 268 
marker intensities in a given sample (Supplementary Figure 3). In our dataset some samples 269 
had significantly skewed and idiosyncratic intensity distributions.  Among these samples there is 270 
an excess of sex chromosome aneuploidies as called by our algorithm, many of which are in fact 271 
errors.  272 
To identify samples with poor performance we first identified 200 random samples with no 273 
chromosomal abnormalities and confirmed that they have quasi-normal intensity distribution in 274 
aggregate.  We then computed a Power Divergence statistic (pd_stat; equivalent to Pearson’s 275 
chi-squared goodness of fit statistic for each sample, comparing to that distribution.  276 
Supplementary Figure 4 shows the distribution of pd_stat values in our entire dataset.  We 277 
selected 3,230 as the threshold, such that in samples with higher values the reported 278 
chromosomal sex could be incorrect. This warning is particularly true for samples reported to 279 
have sex chromosome aneuploidy.  The threshold also ensures that in samples from species 280 
other than Mus musculus, chromosomal sex determination is treated with skepticism. 281 
To determine whether a high pd_stat had an effect on the accuracy of genotyping calls we 282 
selected four pairs of different F1 mice ((A/JxCAST/EiJ)F1_M15765; (CAST/EiJxA/J)F1_F002; 283 
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(CAST/EiJxNZO/HlLtJ)F1_F0019; (CAST/EiJxNZO/HlLtJ)F1_F022; 284 
(NZO/HlLtJxNOD/ShiLtJ)F1_F0042; (NZO/HlLtJxNOD/ShiLtJ)F1_F0042; 285 
(PWK/PhJxNZO/HlLtJ)F1_F0019 and (PWK/PhJxNZO/HlLtJ)F1_M0001) that cover a variety of 286 
pd_stat comparisons (high/low, medium/medium, and low/low).  For each pair we first 287 
determined the pairwise consistency of the genotypes calls and then compared these 288 
genotypes to predicted calls for the consensus reference inbred strains.  Pairwise comparison 289 
consistencies in the autosomes excluding N calls vary between 99.5% and 100%.  Similarly, the 290 
consistency with predicted genotypes is very high (99.5%-100%). We conclude that the pd_stat 291 
is independent of genotype call quality. 292 
Data availability 293 
Genotype calls, hybridization intensity data and consensus genotypes for inbred strains (both 294 
raw and processed) for 6,899 samples are available for download at the Dataverse (upon 295 
acceptance flat files with the data will be posted).  296 
  297 
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RESULTS 298 
Sample set, reproducibility and array annotation 299 
To test the performance of the MiniMUGA array we genotyped 6,899 DNA samples from a wide 300 
range of genetic backgrounds, ages and tissues (Supplementary Table 1).  These samples 301 
include many examples of inbred strains, F1 hybrids, experimental crosses and cell lines (Table 302 
1).  The array content was designed in two phases and thousands of samples were genotyped 303 
to determine the marker performance, information content and to improve different aspects of 304 
the proposed use of the array for genetic QC.  In the initial array that contained 10,171 makers, 305 
5,604 samples were genotyped.  The second phase added 954 markers, with an additional 306 
1,295 samples genotyped.  This results in 6,300 samples that were genotyped once and 225 307 
samples were genotyped two or more times, resulting in a total of 6,525 unique samples.  The 308 
599 replicates were used to estimate the reproducibility of the genotype data.  Overall, 99.6  309 
0.4% of SNP genotype calls were consistent between technical replicates (range 95.9% to 310 
100%).  The consistency rate is similar for replicates run within and between versions of the 311 
array.  Samples with lower consistency rates include wild-derived samples from more distant 312 
species and subspecies (SPRET/EiJ, SFM, SMZ, MSM/MsJ and JF1/Ms), lower quality samples, 313 
and cell lines.  Inconsistency was typically driven by a small minority of markers and by “no 314 
calls” in one or few of the technical replicates.  315 
Probe design and performance of individual assays was used to annotate the array. 316 
Supplementary Table 2 contains the following information: 1) Marker name; 2) Chromosome; 317 
3) Position; 4) Strand; 5-6) Sequences for one and two bead probes; 7-8) Reference and 318 
alternate allele at the SNP; 9) Tier; 10) rsID; 11) Diagnostic information; 12) Uniqueness; 13) X 319 
chromosome markers used to determine the presence and number of X chromosomes; 14) Y 320 
chromosomes markers used to determine the presence of a Y chromosome; 15) Markers added 321 
in the second phase.  322 
Improved chromosomal sex determination reveals sex chromosome aneuploidy due to strain-323 
dependent paternal non-disjunction 324 
Typically, genetic determination of sex of a mouse sample has relied on detecting the presence 325 
of a Y chromosome.  This approach does not estimate X chromosome dosage and thus lacks the 326 
ability to identify samples with common types of sex chromosome aneuploidies.  In contrast, 327 
MiniMUGA uses probe intensity to discriminate between normal chromosomal sexes (XX and 328 
XY) and two types of sex chromosome aneuploidies, XO and XXY (Supplementary Table 1).  The 329 
methodology (Materials and Methods) relies on median autosome-normalized intensity at 269 330 
X chromosome markers and 72 Y chromosome markers.  This approach provides a robust 331 
framework to discriminate between at least four types of chromosomal sex (Figure 1).  Our set 332 
of 6,899 samples was composed of 3,507 unique females (no Y chromosome present) and 3,018 333 
unique males (Y chromosome present).   334 
We initially identified 54 samples as potential XO and XXY.  However, in eight XO females the 335 
pattern of heterozygosity and recombination in the X chromosome (Supplementary Table 6) 336 
demonstrates that these are, in fact, normal XX females with abnormal intensities.  We 337 
developed a new QC test (pd_stat, see Materials and Methods) to identify samples in which 338 
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chromosomal sex determination is not accurate.  Once these eight samples were removed, 46 339 
samples that had sex chromosome aneuploidies remained. To determine the rate of aneuploidy 340 
we only considered unique samples (not replicates). This results in 45 aneuploid samples 341 
among 6,525 total unique samples, an overall 0.7% rate. This rate is driven by a highly 342 
significant excess (7X) of sex chromosome aneuploids among the cell lines.  Notably all these 343 
aneuploids are XO.  Among live mice there were 36 unique aneuploids and the rate is 0.55%, 344 
similar but higher than the reported rate in wild mice and in humans (Searle and Jones 2002; 345 
Chesler et al. 2016; Le Gall et al. 2017).  In this dataset, XO females are observed at significantly 346 
higher frequency than XXY males (p=0.02; 25 XO females and 11 XXY males) (Table 1).   347 
For 22 of the 45 unique samples with sex chromosome aneuploidies, both parents were known 348 
and informative for the X chromosome. This information allowed us to potentially determine 349 
the parental origin of the missing (in XO) or the extra (in XXY) X chromosome based on the 350 
haplotype inherited and recombination patterns observed (Supplementary Table 6; Figure 2).  351 
Overall, the parental origin can be determined unambiguously in 21 of these samples, and in all 352 
but one sample (95%) the aneuploidy is due to sex chromosome non-disjunction in the paternal 353 
germ line (Figure 2).  Note that this applies to both XO and XXY samples.  Given the paternal 354 
origin of most sex chromosome aneuploidies, we investigated whether the type of sire had an 355 
effect.  We observed a highly significantly (p<0.00001) excess of aneuploids in the progeny of 356 
(CC029/Unc x CC030/GeniUnc)F1 hybrid males than in all other sires.  Out of 180 male progeny 357 
of this cross, 5% of genotyped samples were aneuploids and both XO and XXY were observed (3 358 
XO and 6 XXY mice, respectively).  There was also evidence of an excess of sex chromosome 359 
aneuploids in progeny of sires with CC011/Unc background (5 XO females, Supplementary 360 
Table 6).  We conclude that sex chromosome aneuploidy is relatively common in lab mice, 361 
originates predominantly in the paternal germ line and depends on the sire genotype. In some 362 
backgrounds aneuploidy rate is a factor of magnitude higher than in the general population.   363 
Detection of sex chromosome mosaicism 364 
There were eight samples (two classified as XX, three as XXY and three as XO) with abnormal 365 
chromosome Y intensities (either too low or two high) and with low number of chromosome Y 366 
genotype calls (Figure 1).  Because this pattern suggested mosaicism we performed several 367 
additional analyses.  As a test case, we selected the tail-derived sample TL9348 (also named 368 
Unknown, Supplementary Tables 1 and 6) because it was expected to be a F1 hybrid male 369 
derived from a C57BL/6J and 129X1/SvJ outcross, has questionable genotype quality and low 370 
pd_stat.  Based on chromosome intensity this sample was classified as an XXY male with low 371 
chromosome Y intensity.  Inspection of the genotype calls on chromosome X reveals a 372 
significant excess of N calls compared to the autosomes (p<0.00001, Supplementary Table 6).  373 
Furthermore, the H calls are consistent with the expected contribution of the two parental 374 
inbred strains but at only a fraction of expected sites.  These results suggest that the mosaicism 375 
is due to the loss of both the Y chromosome and one of the two X chromosomes in a fraction of 376 
cells.  To test this hypothesis, we plotted the intensity of X chromosome markers for three 377 
types of controls, C57BL/6J and 129X1/SvJ samples and heterozygous females as well as for the 378 
suspected mosaic XXY sample (Figure 3). The pattern shown in this figure explain the observed 379 
mix of N calls, heterozygous calls and C57BL/6J calls in the XXY sample and confirms its mosaic 380 
nature.  It further demonstrates that the X chromosome lost is the 129X1/SvJ one.  Finally, we 381 
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can estimate the fraction of cells with XXY and XO constitution using the distance of each maker 382 
to their corresponding C57BL/6J and het counterparts.  Based on the analysis, we estimate that 383 
approximately half of cells are XXY and the other half XO, a result that is also consistent with 384 
reduction in the Y chromosome intensity by half.  Considered together, these results indicate 385 
that the mosaicism occurred early during development, a common observation in embryo 386 
mosaicism in humans (Johnson et al. 2010; Fragouli et al. 2011; McCoy 2017).   387 
Among the remaining seven potential mosaics, one was a cell line and thus mosaicism of the 388 
sex chromosomes is not unexpected.  For the other six samples we performed a similar analysis 389 
as the one described above.  In all cases the two sets of calls were consistent and thus suggest 390 
chromosome Y mosaicism. However only the two samples with 50 or more genotype calls have 391 
strong support for such a conclusion.  In the Discussion we expand this analysis and provide 392 
some guidance for users of the array.  393 
Strain specific chromosome Y duplications 394 
Among XY males there was a distinct cluster of 64 male samples with higher normalized median 395 
Y chromosome intensity (Figure 1).  These samples include five inbred C3H/HeJ, two F1 hybrid 396 
males with a C3H/HeJ chromosome Y (Figure 4a) and 52 males derived from a C3H/HeJ by 397 
C3H/HeNTac F2 intercross.  The plot of the normalized Y chromosome intensity in these males 398 
and 81 additional males with Y chromosomes derived from other C3H/He substrains (Figure 399 
4a), revealed a clear separation between males carrying a Y chromosome from C3H/HeJ and 400 
males carrying C3H/HeNCrl, C3H/HeNHsd, C3H/HeNRj, C3H/HeNTac and C3H/HeOuJ Y 401 
chromosomes.  Males with the high intensity Y chromosome also include two transgenic strains 402 
from The Jackson Laboratory, B6C3-Tg(APPswe,PSEN1dE9)85Dbo/Mmjax and B6;C3-Tg(Prnp-403 
SNCA*A53T)83Vle/J.  Both strains were developed and/or maintained in B6C3H background 404 
(WEBSITE). 405 
To determine the origin of the higher median intensity in males with a C3H/HeJ Y chromosome, 406 
we plotted the normalized intensities at MiniMUGA markers located on that chromosome 407 
(Figure 4b).  Inspection of this figure indicates that 54 consecutive markers have distinctly 408 
higher intensity and are flanked by markers with intensities that are undistinguishable from 409 
males with other C3H/He Y chromosomes.  These markers define a 2.9 Mb region located on 410 
the short arm of the Y chromosome containing eight known genes Eif2s3y, Uty, Dxd3y, Usp9y, 411 
Zfy2, Sry and Rbmy, and 12 gene models (Figure 4b).  We conclude that C3H/He substrain 412 
differences are due to an intrachromosomal duplication that arose and was fixed in the 413 
C3H/HeJ lineage after the isolation of that substrain in 1952 (Akeson et al. 2006).  There are five 414 
additional non-C3H/He samples with high normalized median chromosome Y intensity, four 415 
technical replicates from a single DBA/1OlaHsd male and a single Axl-/- congenic mouse on a 416 
C57BL/6 background (Figure 4a).  Each case represents a different, independent (different 417 
haplotype and different boundaries, Supplementary Figure 5) and very recent duplication of 418 
the Y chromosome.  These duplications were segregating within a closed colony. Given that we 419 
have identified three independent large segmental duplications of the Y chromosome among 420 
3,018 unique males, we estimate the mutation rate at 1/1000, a relatively high rate.  This is 421 
consistent with the segmental duplications reported in wild mice (Morgan and Pardo-Manuel 422 
de Villena 2017).   423 
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An effective tool for genetic QC in laboratory inbred strains 424 
To determine the performance of MiniMUGA among inbred strains we genotyped 779 samples 425 
representing 241 inbred strains including 86 classical inbred strains, 34 wild-derived inbred 426 
strains, 49 BXD recombinant inbred lines and 72 CC strains (Supplementary Table 3).  We 427 
created consensus genotypes for each inbred strain using both biological and technical 428 
replicates (see Materials and Methods).  The use of replicates strengthen the conclusions that 429 
can be made from our genetic analyses as they provide a simple but robust method to 430 
determine the performance of each SNP in each strain (see Discussion) as well as determining 431 
the dates when diagnostic alleles arise and potentially became fixed (see below). We note that 432 
for the CC strains, which are incompletely inbred (Srivastava et al. 2017), our consensus calls 433 
were based on a small number of samples. As such, these consensuses may not completely 434 
reflect the individual genotype of any CC animal from a specific strain. Future sampling of a 435 
wider range of genotypes from CC mice throughout the history of the CC colony will assist in 436 
more accurate consensus genotypes for these strains.  437 
Using the consensus genotypes we determined the number of informative markers for pairwise 438 
combinations of all inbred strains.  Figure 5 summarizes the results for 83 classical inbred 439 
strains.  Over 90% of comparisons have at least 1,280 informative autosomal markers and all 440 
but 0.52% of pairwise comparisons have more than 40 informative autosomal markers (2.1 441 
markers per autosome).  These statistics are exceptional given the limited number of markers in 442 
the array, the inclusion of a large number of diagnostic markers, and a substantial number of 443 
construct markers.  Although our focus is on classical inbred strains, we extended the analysis 444 
to include 37 wild-derived strains.  For all 2,924 combinations of classical and wild derived 445 
strains, the informativeness is high (mean = 3,224, min = 1,649, max = 3,827).  In marked 446 
contrast, combinations between wild-derived strains have a much wider range of informative 447 
SNPs (from 93 to 3,410) due to a significant fraction of combinations with few to moderate 448 
number of informative SNPs.  The pairs of strains with the lowest number of informative SNPs 449 
include pairs of strain from a taxa other than Mus musculus (for example SPRET/EiJ, SMZ and 450 
XBS) and pairs of strains that are known to have close phylogenetic relationships (TIRANO/EiJ 451 
and ZALENDE/EiJ; and PWD and PWK/PhJ; (Yang et al. 2011)).  We conclude that MiniMUGA is a 452 
significant improvement for genotyping standard lab strains and experimental crosses derived 453 
from them.  454 
Mitochondria 455 
MiniMUGA has 88 markers that track the mitochondrial genome, 82 of which segregate in our 456 
set of 241 inbred strains.  Based on these 82 markers, the inbred strains can be classified into 457 
22 different haplogroups, 19 of which discriminate between M. musculus strains (Figure 6a).  458 
Fifteen haplotypes represent M. m. domesticus (groups 1 to 15 in Figure 6a), and two 459 
haplotypes represent M. m. musculus (16 and 17) and two M. m. castaneus (18 and 19).  Three 460 
haplotypes represent different species such as M. spretus and M. macedonicus.   461 
In M. musculus, nine haplotypes are present in multiple inbred strains while 10 are found in a 462 
single inbred strain.  The most common haplotype is present in 158 inbred strains (including 49 463 
BXD and 26 CC strains).  This haplotype is found in many classical inbred strains including 464 
C57BL6/J, BALB/cJ, A/J, C3H/HeJ, DBA/1J , DBA/2J and FVB/NJ.  Unique haplotypes represent an 465 
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interesting mix of wild-derived strains (LEWES/EiJ, CALB/Rk, WMP/Pas, SF/CamEiJ, TIRANO/EiJ, 466 
ZALENDE/EiJ, CIM) and DBA/2 substrains (DBA/2JOlaHsd and DBA/2NCrl).  CC strains fall into six 467 
common haplotypes, one shared by CC three founders A/J, C57BL/6J and NOD/ShiLtJ and five 468 
haplotypes present in a single CC founder: PWK/PhJ, 129S1/SvImJ, CAST/EiJ, NZO/HlLtJ and 469 
WSB/EiJ. Interestingly, SMZ, a wild-derived inbred strain of M. spretus origin, has a 470 
mitochondrial haplotype that unambiguously cluster with M. m. domesticus (Figure 6a) 471 
demonstrating a case of interspecific introgression.  472 
Chromosome Y 473 
MiniMUGA has 75 markers that track the Y chromosome, 57 of which segregate in our set of 474 
189 inbred strains with at least one male genotyped.  Based on these 57 markers, the inbred 475 
strains can be classified into 18 different haplogroups, 16 of which are M. musculus (Figure 6b). 476 
Only four haplotypes represent M. m. domesticus, two haplotypes represent M. m. castaneus 477 
and 11 represent M. m. musculus.  M. spretus and M. macedonicus are represented by a single 478 
haplotype each.  In M. musculus, all but one haplotype (CIM) are present in multiple inbred 479 
strains.  No single haplotype dominates in our collection of inbred strains (the most common is 480 
present in 38 inbred strains).  Interestingly, C57BL/6 substrains fall into three distinct 481 
haplotypes.  The ancestral haplotype is found in C57BL/6ByJ, C57BL/6NCrl, C57BL/6NHsd, 482 
C57BL/6NJ, C57BL/6NRj and B6N-Tyr<c-Brd>/BrdCrCrl.  This haplotype is present in other 483 
classical inbred strains such as BALB/c, C57BL/10, C57BLKS/J, C57L/J and C58/J.  The second 484 
haplotype is present in C57BL/6JBomTac, C57BL/6JEiJ and C57BL/6JOlaHsd.  Finally, C57BL/6J 485 
has its own private haplotype shared with 10 CC strains.  Each one of the eight founder strains 486 
of the CC (A/J, C57BL/6J, 129S1/SvImJ, NOD/ShiLtJ, NZO/HlLtJ, CAST/EiJ, PWK/PhJ and WSB/EiJ) 487 
has its own distinct haplotype.  488 
Diagnostic SNPs as tool for genetic QC and strain dating 489 
Almost 30% of the SNPs in MiniMUGA are diagnostic for a specific genetic background and were 490 
selected from whole genome sequence of 45 classical inbred strains (Table 2).  We define SNPs 491 
as diagnostic when the minor allele is present only in a single classical inbred strain or in a set of 492 
closely related substrains.  The identification of these SNPs requires WGS from the 493 
corresponding strain using the sequence of 12 publicly available strains (Keane et al. 2011; 494 
Adams et al. 2015), 33 substrains that we sequenced and SNP data for the C57BL/10 strain 495 
group (Table 2).  We sequenced these substrains to develop MiniMUGA as well as the desire to 496 
expand the number of strains amenable to RCC (MTF, unpub.).  Although diagnostic SNPs have 497 
low information content (i.e., most samples in a large set of genetically diverse mice will be 498 
homozygous for the major allele) they fulfill these two critical missions.  First, they increase the 499 
specificity of the MiniMUGA array to identify the genetic background present in a sample.  In 500 
addition, they are essential to extend the power of genetic mapping in RCC beyond the 501 
C57BL/6J-C57BL/6NJ paradigm (Kumar et al. 2013; Treger et al. 2019). 502 
The 3,045 diagnostic SNPs can be divided into two classes based on whether they are diagnostic 503 
for a specific substrain (i.e., BALB/cJBomTac or C3H/HeJ) or a strain group (i.e., BALB/c or 504 
C3H/He).  There are 2,408 SNPs that are diagnostic for one of 45 substrains and 637 SNPs 505 
diagnostic for one of 10 strain groups (Table 2).  A second classification divides diagnostic SNPs 506 
into 2,910 fully diagnostic and 129 partially diagnostic SNPs.  The difference between these two 507 
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classes is based on whether the diagnostic allele was fixed or was still segregating in the 508 
samples used to determine the consensus genotypes of 46 classical inbred strains.   509 
All diagnostic SNPs started as partially diagnostic SNPs and they highlight the often overlooked 510 
fact that mutations arise in all stocks and some of them are fixed despite the best efforts to 511 
reduce their frequency and impact.  It should be theoretically possible to date when fully and 512 
partially diagnostic SNPs arose and whether and when the became fixed in the main stock of an 513 
inbred strain.  This requires sampling a given substrain at known dates in the past in large 514 
enough cohorts to make confident inferences, in other words genotype large cohorts isolated 515 
from the main breeding line at known dates.  516 
We have two such populations in our sample set, the BXD and the CC recombinant inbred lines 517 
(RIL).  In the former we determined whether diagnostic alleles for C57BL/6J and DBA/2J were 518 
present in 49 BXD RILs.  These RIL were generated in three different epochs: 22 of the 519 
genotyped BXD lines belong to epoch I (E1, (Taylor et al. 1973)); four belong to epoch II (E2, 520 
(Taylor et al. 1999)) and 23 belong to epoch III (E3, (Peirce et al. 2004)).  We determined 521 
whether the minor allele at diagnostic SNPs was observed first in epoch I, epoch II, or epoch III. 522 
SNPs that were not observed in any of these epochs were grouped under the heading of post 523 
E3.  Table 4a summarizes these findings and further classifies the SNPs based their diagnostic 524 
information.  We find similar patterns for C57BL/6J and DBA/2J diagnostic SNPs with epoch II 525 
contributing the majority of diagnostic SNPs, and epochs III and IV contributing approximately 526 
half each of the remaining SNPs.  Epoch I SNPs are rare except for the DBA/2 strain group.  527 
Finally, and as expected, all partial diagnostic SNPs for C57BL/6J belong to post E3.   528 
The CC population offers another opportunity to annotate diagnostic SNPs as these RIL were 529 
derived from mice from eight inbred strains in 2004 (Collaborative Cross Consortium 2012), 530 
including four strains with diagnostics SNPs in MiniMUGA, C57BL/6J, A/J, 129S1/SvImJ and 531 
NOD/ShiLtJ.  We used 483 CC samples genotyped in the initial array to determine when these 532 
334 diagnostic SNPs arose.  We observe three types of patterns depending on the age of the 533 
diagnostic allele: 1) the diagnostic allele is fixed in the CC population and thus the diagnostic 534 
allele predates the start of the CC project in 2004; 2) the diagnostic allele is absent the CC 535 
population and thus the diagnostic allele arose after 2004; and 3) the allele is segregating in the 536 
CC with some strains having fixed the diagnostic allele while it is absent in other CC strains.  537 
Table 4b summarizes these findings.   538 
In addition to determining when diagnostic SNPs arose, it is possible to estimate whether and 539 
when the became fixed by examining the allele frequency at consecutive time points and for 540 
consistency between populations.  This is best exemplified for diagnostic SNPs of the C57BL/6J 541 
substrains as we have two time points with substantial sampling, E3 with 23 BXD RIL and the 542 
initiation of the CC with 72 CC RIL (note that only one eighth of them will have the C57BL/6J 543 
haplotype at any given location and thus the real size of the population used to estimate 544 
fixation is closer to 9). There are 75 SNP that were labelled as fixed at E3 because they had 545 
100% allele frequency in both BXD RIL and CC RILs with a C57BL6/J haplotype at the locus.  546 
There are also 49 SNPs that were labelled as fixed at the start of the CC because they had 100% 547 
allele frequency in CC RILs with a C57BL6/J haplotype at the locus.  The remaining 26 diagnostic 548 
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SNPs were segregating or arose after the start of the CC project.  The dates of origin and 549 
fixation for diagnostic SNPs are provided in Supplementary Table 2. 550 
The birth and fixation of diagnostic alleles can be used to determine the origin and breeding 551 
history of a given sample of the appropriate background and thus estimate the expected level 552 
of drift (see Discussion).  553 
Expansion of reduced representation crosses to a large number substrains 554 
We define RCC as crosses between substrains from a single laboratory strain that differ only at 555 
mutations that arose after they were isolated and bred independently from the common inbred 556 
stock.  We tested the ability of MiniMUGA to efficiently cover the genome in 78 different RCC 557 
between substrains for which we have consensus genotypes, whole genome sequences and for 558 
which live mice are available from commercial vendors (see Table 2).  We focus our analysis in 559 
this group given that WGS of both substrains is required for rapid identification of causative 560 
variant(s) (Kumar et al. 2013; Treger et al. 2019).  We used the distance to the nearest 561 
informative marker to estimate how well MiniMUGA covers the genome in a given RCC cross.  562 
Figure 7 summarizes these data and demonstrates that for 62 RCCs (82%) all of the genome is 563 
covered by a linked marker and in 14 RCCs (18%) between 95% and 99.5% of the genome is 564 
covered by a linked marker.  Only in two RCCs (3%) there is a significant fraction genome that is 565 
not covered by a linked marker.  These two crosses are B6N-Tyr<c-Brd>/BrdCrCrl by 566 
C57BL/6JOlaHsd and BALB/cByJ by BALB/cByJRj with 8% and 14% of the genome not covered, 567 
respectively.  An alternative test is the number of RCCs for which 95% of the genome is covered 568 
by informative markers at 20cM (56 RCCs or 72%) and 40cM (72 RCCs or 92%) intervals.  We 569 
conclude that MiniMUGA provides a cost effective tool to extend RCC to substrains from the 570 
129P, 129S, A, BALB/c, C57BL/6, C3H, DBA/1, DBA/2, FVB and NOD strains. 571 
Robust detection of common genetic constructs  572 
Given the broad usage of genetic editing technologies, a key design criterion of MiniMUGA was 573 
the ability to detect frequently used genetic constructs. Utilizing our pipeline (low construct 574 
probe intensity in classical inbred and F1 samples; variable intensity across the rest of our test 575 
population), we positively identified samples containing 17 construct types (Figure 8).  576 
Importantly, for eight of these constructs, our sample set included positive controls. These 577 
positive controls showed robust detection of their relevant constructs. We detected further 578 
positive samples from our set in both these eight constructs, as well as nine additional 579 
construct classes. All such samples were in sample classes where constructs were plausible (e.g. 580 
not wild-derived or CC samples), and there was high concordance for intensities among the 581 
probes comprising the detection sets for each of these constructs.  582 
For constructs with many probes (Supplementary Figure 6, Supplementary Table 8), we 583 
noticed that samples we declared as positive could often have significant sample-to-sample 584 
variation in their overall intensity (Figure 8). As described in the methods and Supplementary 585 
Table 8, for some construct types our analysis suggested that some probes designed for 586 
different constructs were in fact detecting conserved features among multiple construct types 587 
(e.g. our ‘g_FP’ designation encompasses probes designed against green-, yellow-, and cyan- 588 
fluorescent proteins). As such, it is possible that only a subset of our validated probes are 589 
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detecting any given sample’s construct. Given our ability to positively identify construct classes 590 
with as few as two probes, it is likely that even for constructs which have divergent sequences 591 
from our designed sequences, or are targeting a more distantly related construct type, our 592 
pipeline will flag samples. An alternative explanation for signal heterogeneity within a construct 593 
class is due to within-sample heterogeneity. That is, samples either have variable copies of the 594 
construct in question. Such observations might be more common in cell culture samples. 595 
Alternatively, construct mosaicism in live animals may manifest as an intermediate signal for 596 
given constructs. 597 
As inferred from the above section, across these 17 constructs, we observed that our ability to 598 
discriminate between negative and positive samples across these 17 constructs is strongly 599 
correlated with the number of independent probes for that construct (Supplementary Figure 2, 600 
Figure 8). As signal intensity is constrained by the dynamic range, our ability to definitively call 601 
the presence of low probe number constructs is more uncertain. This uncertainty is especially 602 
relevant where a given construct is genetically divergent from the construct sequences used to 603 
define a given probe. Users are highly encouraged to consult the probe sequences when they 604 
expect a given sample to contain a construct, but do not see support in the array itself. 605 
Conversely, for constructs with many independent probes, positive support for a construct is 606 
more conclusive, even if a given sample is not expected to contain any constructs. 607 
Finally, we designed probes for 14 constructs, which universally failed in our pipeline. That is, 608 
the intensity distributions between known negative (classical inbred strains from commercial 609 
vendors and F1 hybrids) and experimental samples were not different. The easiest explanation 610 
for these differences is that no samples within our set contained these constructs. Consistent 611 
with this explanation is our a priori knowledge that no samples in our set could be defined as 612 
known positives. In this case, probe-sets may in fact be diagnostic and individual users may 613 
identify between sample intensity differences for these constructs. However, as the above 614 
sections and methods caution, direct interpretation of single probes or probe-sets are 615 
challenging without larger context. Alternatively, though less likely, is that our probe-sets will 616 
fail regardless of construct presence. Definitive testing of construct-positive and construct-617 
negative samples for these probe-sets in the future will provide definitive answers to these. 618 
An easy to interpret report summarizes the genetic QC for every sample 619 
The MiniMUGA Background Analysis Report (Figure 9) aims to provide users with essential 620 
sample information derived from the genotyping array for every sample genotyped.  The report 621 
is designed to provide overall sample QC, as well as genetic background information for 622 
classical inbred mouse strains, congenic, and transgenic mice.  For samples outside of this scope 623 
the report may be incomplete or provide misleading conclusions.  Details of the thresholds and 624 
algorithms for each section of the report are provided in the Materials and Methods section. 625 
In addition to chromosomal sex and presence of constructs, the report provides a quantitative 626 
and qualitative score for genotyping quality. Based on the number of N calls per sample of our 627 
sample set we classified samples in one of four categories: samples with Excellent quality (0 to 628 
91 N calls, represents 96.8% of samples); samples with Good quality (between 92 and 234 N 629 
calls, 2% of samples), samples with Questionable quality (between 235 and 446 N calls, 0.9% of 630 
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samples) and samples with Poor quality (more than 447 N calls, 0.3% of samples).  Only tier 1 631 
and 2 markers were used in this analysis.  632 
Regarding inbreeding status, the report assigns every sample to one of three categories: Inbred 633 
(fewer than 61 H calls), close to inbred (between 61 and 280 H calls) and outbred (more than 634 
280 H calls). These thresholds are based on the number of H calls observed in the autosomes of 635 
172 samples of classical inbred strains and predicted heterozygosity in 3,655 in silico F1 hybrid 636 
mice (Supplementary Figure 7).   637 
For genetic QC, the report provides two complementary analyses.  One analysis determines the 638 
primary and secondary background of a qualified sample based on the totality of its genotypes 639 
(excluding the Y chromosome). The second returns the genetic backgrounds detected in a 640 
sample based on the presence of the minor allele at diagnostic SNPs (see section on diagnostic 641 
SNPs as tool for genetic QC and strain dating).  The initial diagnostic analysis uses the presence 642 
of minor alleles in the sample genotypes at identified diagnostic SNPs to identify which (if any) 643 
of 46 substrains and/or 10 strain groups are present in the sample.  644 
For the primary background analysis, the sample’s genotype is compared to a set of 120 645 
classical and wild-derived inbred reference strains (Supplementary Table 3) to identify the 646 
strain that best explains the sample genotypes.  If multiple substrains from the same strain 647 
group have been detected via diagnostic alleles, or if there is an overrepresentation of a 648 
particular diagnostic strain in the unexplained markers, the algorithm generates a composite 649 
strain consensus that incorporates all substrains in that strain group and uses it in the primary 650 
background analysis. The strain or combination of substrains that best matches the sample is 651 
called the primary background for the sample.  The report provides the number of homozygous 652 
calls that are consistent or inconsistent with the primary background, as well as the number of 653 
heterozygous calls in the sample. The primary background is always returned for samples in 654 
which the primary background explains at least 99.8% of the sample genotype calls.  655 
Once the primary background is determined, the algorithm tests whether at least 75% of the 656 
markers inconsistent with the primary strain background or heterozygous (aka unexplained) are 657 
spatially clustered. If they are not (<75% of markers spatially clustered) the algorithm will not 658 
try to identify a secondary background. If at least 75% of the unexplained markers are 659 
clustered, all strain(s) from the reference set that best explain at least half of the unexplained 660 
calls are identified as secondary background(s).  If the combination of primary and secondary 661 
backgrounds explains at least 99.8% of the calls, the primary and secondary backgrounds are 662 
reported. If it explains <99.8% then no genetic background is returned.  663 
For samples where a primary and secondary background is reported, the algorithm determines 664 
whether the remaining unexplained markers are spatially clustered. If they are, the summary 665 
states that clustering of unexplained markers may indicate the presence of an additional 666 
genetic background. The limitations of this greedy approach to identification of the primary and 667 
secondary backgrounds are further explained in the Discussion section. 668 
Note that this report is generated programmatically using the available reference inbred strains 669 
(Supplementary Table 3).  If the reported results are inconsistent with expectations, users need 670 
to consider further analyses before reaching a final conclusion.  All estimates and claims in the 671 
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report are heavily dependent on the quality of the sample and genotyping results.  Less than 672 
excellent genotyping quality will likely increase the likelihood of an incorrect conclusion. 673 
Genotyping noise can lead to incorrect reporting and may be particularly misleading in samples 674 
from standard commercial inbred strains.  Fully inbred strains routinely have a small percentage 675 
of spurious H calls.  These do not represent true heterozygosity (see consensus of inbred 676 
strains). 677 
Cell lines 678 
Cell lines can be subject to the same genetic QC as mice.  We have previously reported that the 679 
number of N calls is higher for cell lines that mixed tissues in other arrays (Didion et al. 2014).  680 
There is some evidence of this in our dataset but it is inconclusive.  We have already shown the 681 
ability to detect sex chromosome aneuploidy in cell lines (Figure 1).  Diagnostic SNPs can be use 682 
to date cell lines in similar fashion with the added simplicity that cell lines are less susceptible to 683 
change.  Finally, cell line can be run the same Background Analysis Report pipeline discussed in 684 
the previous section, some examples are provided in Supplementary Figure 8.  The importance 685 
of genetic QC in cell lines will grow in future given the increased emphasis on cell based 686 
research.  687 
 688 
DISCUSSION 689 
MiniMUGA as a tool for QC 690 
Among the many new capabilities of the MiniMUGA array compared with its predecessors is 691 
the Background Analysis Report provided with each genotyped sample.  Although expert users 692 
can, and undoubtedly will, refine existing and develop new analyses pipelines; all users benefit 693 
from a common baseline developed after the analyses of many thousands of samples.  The size, 694 
annotation, and variety of our sample set provided a firm foundation for the results and 695 
conclusions presented here.   696 
We urge users to pay particular attention to genotype quality, reported heterozygosity and 697 
unexpected conclusions (i.e., sex, backgrounds and constructs detected).  Genotype quality 698 
depends on the sample quality, quantity and purity and on the actual genotyping process.  Poor 699 
sample quality can also be the byproduct of off target variants in the probes used for 700 
genotyping and thus wild mouse samples and mice from related taxa are expected to have 701 
lower apparent quality.  Samples with poor quality will not be run through the report.  Samples 702 
with questionable quality may lead to incorrect conclusions.  For samples of any quality the 703 
total number of N calls should be carefully considered if unexpected results are reported. It is 704 
also important to consider the pd_stat when evaluating the chromosomal sex determination. 705 
Reported heterozygosity is sensitive to genotyping quality.  A lower quality sample will typically 706 
include more spurious heterozygous calls than an excellent quality sample of the same strain. 707 
This leads to an incorrect estimate of the level of inbreeding in a given sample, and can be 708 
particularly misleading in a fully inbred mouse of pure background.  The thresholds used to 709 
classify samples as inbred, close to inbred and outbred are somewhat arbitrary and reflect the 710 
biases in SNP selection (overrepresentation of diagnostic SNPs for selected substrains) and the 711 
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highly variable range of diversity observed in F1 mice.  We used the observed number of H calls 712 
in known inbred samples and the predicted number of H calls among a large and varied set of 713 
potential F1 hybrids to set our thresholds, but users should define the level of heterozygosity in 714 
a specific experiment (Supplementary Figure 7).  For example, mice generated in RCCs between 715 
related substrains may have a very small number of H calls and thus will be misclassified as 716 
more inbred that they really are.  The report combines sample quality and heterozygosity in a 717 
single figure for quick visual inspection.  Note that the x and y axes are compressed in the high 718 
value range to ensure that all samples, even those with very poor quality and/or high 719 
heterozygosity, are shown.  The precise location of a sample in the plot should help customers 720 
contextualize their sample’s quality and inbreeding when evaluating their results. 721 
For users genotyping large number of samples in a given batch (for example, several 96 well 722 
plates) we found it useful to include a plate-specific control at an unambiguous location (we use 723 
the B3 well).  Ideally, these controls have known genotypes, excellent quality and are easy to 724 
distinguish from all other samples in the batch.  Plating errors or unaccounted transpositions 725 
occurring during the genotyping process are rare but problematic.  Adding one sample per plate 726 
is a reasonable cost to quickly identify these issues before they metastasize.  727 
We anticipate that most users will use the Background Analysis Report to determine the genetic 728 
background(s) present in a sample as well as their respective contributions.  The identification 729 
of the correct primary and secondary background is completely dependent on the pre-existing 730 
set of reference strains (Supplementary Table 3).  If a genotyped sample is derived from a 731 
strain that is not part of this reference set, the reported results may be misleading or 732 
completely incorrect. Users should consult the list of reference backgrounds.  We expect the 733 
number of reference backgrounds to increase over time, reducing the frequency and impact of 734 
this problem.  However, the current background detection pipeline is not appropriate for 735 
recombinant inbred lines (RIL) such as the BXD and CC populations.  By their very nature RIL 736 
have mosaic genomes derived from two or more inbred strains (included in our panel) and thus 737 
the background analysis will detect more than two inbred backgrounds (for CC strains) or 738 
declare one of the parental strains as a secondary background in some specific cases.  Users 739 
interested in confirming or determining the identity of RIL can use our consensus genotypes to 740 
do so.   741 
An important caveat of the current primary and secondary background analysis is that the 742 
approach is greedy, and all variants except those with H and N calls in the consensus are 743 
considered.  Because only a fraction of the SNPs are informative between a given pair of strains 744 
(typically less than half, see Figure 5 and Supplementary Figure 7), the algorithm always 745 
overestimates the contribution of the primary background and underestimates the contribution 746 
of the secondary background (Figure 9).  As a general rule in congenic strains, the contribution 747 
of the strain identified as the secondary background should be multiplied by at least 3.  If the 748 
exact contribution of either background is critical for the research question, the user should 749 
reanalyze the data using only SNPs that discriminate between the two backgrounds.  750 
A second caveat is that the current pipeline does not include the mitochondria and Y 751 
chromosomes’ genome. This shortcoming will be addressed in a future update of the 752 
Background Analysis Report.  753 
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A final caveat is that in most cases if more than two inbred strains are needed to explain the 754 
genotypes of a sample, the report does not identify any of them.  In our experience when three 755 
of more backgrounds are present a greedy search is not effective and often leads to incorrect 756 
results.  If the user has prior knowledge of at least some of the backgrounds involved, an 757 
iterative hierarchical search will typically yield the correct solution, but care needs to be taken 758 
at each step.  759 
Genetic constructs have been a staple of genome editing technologies since the 1980s. In 760 
addition to desired genetic modifications, constructs will often include a variety of other 761 
necessary features (e.g. selection markers; constitutive promoters).  The array can be used to 762 
validate the presence of constructs expected to be present and/or to identify unexpected 763 
constructs.  764 
Our construct probe design was focused on targeting conserved features of various genetic 765 
engineering and/or in vitro constructs commonly used in mammalian genetics. We can split 766 
these conserved probe-sets into two main classes: those for which we were able to detect 767 
positive samples in this large cohort, and those for which we were not able to detect any 768 
consistently positive signal/sample.  Many of the probe-sets that are reported jointly as a single 769 
construct type because the signals were highly correlated (e.g. the cyan, green and yellow 770 
fluorescent protein probe-sets).  Interested users can use the individual probe intensities to 771 
refine the analysis.  772 
Similarly, in the dataset used to define the performance of the array, we were unable to 773 
identify samples positive for several individual probes and even some entire probe-sets 774 
(Supplemental Figure 6).  In some cases we excluded probes due to the fact that they work for 775 
different subsets of samples than the included probes (see hTK_pr in Supplementary Figure 6). 776 
In other cases, the excluded probes failed for an unknown reason and likely cannot be rescued 777 
(iCRE in Supplementary Figure 6). Finally, addition of known positive controls may allow the 778 
rescue of one or more of the 13 constructs targeted (e.g. ampicillin resistance Supplementary 779 
Figure 6). 780 
MiniMUGA as a tool for discovery 781 
MiniMUGA was designed to support the research mission of geneticists, but the range of 782 
applications will depend on the ingenuity of its users.  In the results sections we explored three 783 
areas in which MiniMUGA has high potential to complement existing resources and tools.  784 
The first of these areas is sex chromosome biology.  MiniMUGA is able to robustly determine 785 
four sex chromosome configurations (Figure 1) and thus facilitates estimation of the incidence 786 
and prevalence of sex chromosome aneuploidy in the mouse.  The variation of aneuploidy rates 787 
depending on the sire background provides a promising avenue to study the genetics of sex 788 
chromosome missegregation.  In addition, identification of aneuploid mice can become routine 789 
in experimental cohorts and crosses.  This is also important in colony management, as XO and 790 
XXY mice are likely to be infertile or have reduced fertility (Heard and Turner 2011).   791 
This type of analysis can also identify sex chromosome mosaicism (Johnson et al. 2010; Fragouli 792 
et al. 2011; McCoy 2017) and large structural variants involving the sex chromosomes.  In the 793 
results section we have shown that mosaics are outliers from the four defined clusters 794 
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observed in the intensity based chromosome sex determination plot (Figure 1). Specifically, 795 
they have abnormal Y chromosome intensities.  These mosaics may also have an abnormally 796 
high ratio of N calls in the X chromosome compared to the autosomes and chromosome X 797 
marker intensity distributions biased towards one parent (Figure 3).  The last analyses are only 798 
possible in the presence of heterozygosity on the X chromosome.  799 
In addition, MiniMUGA revealed a 6Mb de novo duplication of the distal chromosome X 800 
(Supplementary Figure 9) in an F2 male.  The size of this duplication is not large enough to 801 
affect chromosomal sex determination and its discovery was due to the presence of 10 802 
heterozygous calls clustered on distal X.  These heterozygous calls occur at informative markers 803 
between the two CC strains involved in the F2 cross and are embedded in a region of 26 804 
consecutive markers with higher than expected intensity (Supplementary Figure 9).  805 
Interestingly, the parental CC strains (CC029/Unc and CC030/GeniUnc) are the same for which a 806 
10X increase in sex chromosome aneuploidy is observed. We concluded that this F2 male had a 807 
sharply defined duplication of the distal X chromosome.  These vignettes provide a potential 808 
blueprint that can be extended to other chromosomes and structural variants.  It also highlights 809 
the importance of having a large set of well-defined genotyped controls, against which to 810 
compare a given sample. 811 
A second area of potential research is the expansion of the RCC paradigm beyond the narrow 812 
confines of C57BL/6N (Kumar et al. 2013; Babbs et al. 2019; Treger et al. 2019).  A successful 813 
RCC requires complete knowledge of the sequence variants shared and private to the set of 814 
substrains that will be used in the mapping experiments.  These private variants are obviously 815 
needed to infer causation but also in the initial step of genetic mapping.  We acknowledge that 816 
the development of MiniMUGA was made possible by the efforts of the community to 817 
sequence an increasing number of inbred strains.  The expansion of RCCs to 129S, A, BALB/c, 818 
C57BL/6, C3H, DBA/1, DBA/2, FVB and NOD substrains should increase the total number of 819 
accessible private mutations by at least one order of magnitude; and therefore, we should 820 
expect a similar increase in the number of mappable causative genetic variants for biomedical 821 
traits.  We note that even as substrains continue to accumulate private variants in an 822 
unpredictable manner, MiniMUGA will retain its value for genetic mapping but additional WGS 823 
will be required.   824 
Finally, the private variants that underlie the RCC concept are the diagnostic variants used in 825 
background determination and sample dating.  Diagnostic SNPs have little information content 826 
but high specificity.  The presence of diagnostic alleles in a sample is strong evidence that that 827 
specific substrain (or a closely related substrain absent from our set) contributed to the genetic 828 
background of that sample.  However, because only a small fraction of diagnostic SNPs have 829 
been observed in all three genotypes across multiple samples, their performance is not well 830 
established, in particular for heterozygous calls.  To avoid errors, we required diagnostic alleles 831 
at three different SNPs in a given sample before a genetic background is declared in the 832 
Background Analysis Report.  All diagnostic SNPs began their history as partially diagnostic 833 
(segregating in an inbred strain or substrain population).  834 
To test whether it is possible to use the annotated diagnostic SNPs to determine the age and 835 
breeding history of a given sample or stock we selected 485 samples that where over inbred, 836 
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had over 99% identity to C57BL/6J and had no diagnostic alleles for any other substrain.  The 837 
analysis is based in the pattern of ancestral diagnostic SNPs that are classified as fixed in epoch 838 
III (E3) or prior to the CC based.  Figure 10 shows three examples with different patterns.  Panel 839 
A shows a KO mouse from line created prior to epoch III (E3) and bred independently from the 840 
C57BL/6J stock since at least 2004. The former conclusion is based the fact that we detect the 841 
ancestral allele at 21 SNPs that were fixed prior to epoch III. The later is based in the 842 
observation of ancestral alleles at 36 SNPs that we believe to be fixed by 2004 (21 and 15 from 843 
E3 and CC, respectively) and that these markers are distributed across 14 chromosomes.  Panel 844 
B shows a transgenic mouse from a line created prior to the initiation of the CC (2004) and bred 845 
independently from the C57BL/6J stock since them.  Both conclusions are based the fact that 846 
there are zero ancestral alleles at any of 75 diagnostic SNPs fixed by epoch III, the detection of 847 
the ancestral allele at 18 SNPs that were fixed prior to the CC and that these markers are 848 
distributed across 13 chromosomes.  Finally, panel C shows a wild type C57BL/6J mouse derived 849 
from the JAX colony after 2004.  The conclusion is based in the lack of ancestral alleles at any of 850 
124 fixed diagnostic SNPs and the presence of a derived allele at three SNPs that arose after the 851 
CC.  Notably our conclusions were consistent with the expectations from the owners of these 852 
samples.  However, these are fairly simple examples but more complex and more interesting 853 
patterns are plentiful in our dataset.  For example, four samples from a congenic inbred stock 854 
show evidence of both an old stock and new refreshing of the genome in recent years 855 
(Supplementary Figure 11).  Specifically, the presence of ancestral alleles at many diagnostic 856 
SNPs fixed prior to epoch III and the start of the CC speaks of mouse line generated and bred 857 
independently for many years. On the other hand, heterozygosity at some of these markers as 858 
well as the presence of post CC diagnostic alleles indicates that this line we refreshed by 859 
backcrossing to C57BL/6J in recent years. Both conclusions are correct as this stock was 860 
imported by Mark Heise at UNC in 2014 and backcrossed once or a few times to JAX mice 861 
before being maintained by brother sister mating.  In addition to improving the genetic QC, we 862 
believe that this type of analysis may provide researchers with critical information to guide 863 
both experimental design and data analysis.  Most important is the ability to estimate the 864 
amount of drift that has taken and thus the amount of genetic variation present in that line but 865 
absent in the main stock.  We expect that use of MiniMUGA and the continued and rapid 866 
annotation of diagnostic SNPs not only for C57BL/6J but for all inbred substrains offers an 867 
opportunity to significantly improve the rigor and reproducibility of mouse research. 868 
 869 
 870 
  871 
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TABLES 994 
Table 1 995 
 996 
 997 
 998 
 999 
  1000 
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Table 2 1001 
 1002 
 1003 
  1004 
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Table 3 1005 
 1006 
 1007 
 1008 
 1009 
  1010 
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Table 4 1011 
 1012 
 1013 
 1014 
 1015 
 1016 
  1017 
A)
Epoch Full Partial Full Partial C57BL/6 DBA/2 Other
I 0 0 4 0 2 24 1 0 0
II 72 0 68 0 4	(2) 0 0 0 1*
III 34 0 16 0 0 0 0 0 0
IV 30 20 24 0 0 0 0 0 0
B)
Full Partial Full Partial Full Partial Full Partial
PreCC 47 0 116 7 75 6 34 0
During	CC 8 3 16 7 2 4 2 0
PostCC 0 2 0 3 0 1 0 1
NOD/ShiLtJ
C57BL/6J DBA/2J C57BL/6	
group
DBA/2J	
group
A/J C57BL/6J 129S1/SvImJ
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FIGURES 1018 
Figure 1.  Chromosomal sex determination in 6,899 samples.  Each dot and cross represents 1019 
one sample.  The x value is the autosome normalized median sample intensity at 269 sex 1020 
informative X chromosome markers, and the y value is the autosome normalized median 1021 
sample intensity at 72 sex informative Y chromosome markers.  The dot color denotes the 1022 
assigned chromosomal sex: XX, red; XY, blue; XO, green; XXY, purple. Potential mosaic samples 1023 
are shown in gray and known errors in yellow.  Samples with normal pd_stat as shown as circles 1024 
and samples with high pd_stat are shown as crosses. 1025 
Figure 2.  Paternal origin of most sex chromosome aneuploids.  Only the sex chromosomes and 1026 
the mitochondria are shown. The X chromosomes are shown as acrocentric, Y chromosomes as 1027 
submetacentric and mitochondria as circles.  The parents of two types of crosses (outcross or 1028 
intercross) are shown at the top of the figure with the dam shown on the left and the sire on 1029 
the right.  The potential types of aneuploid progeny in each type of cross are shown with the 1030 
parental origin below. The figure also shows the inferred parental origin of the aneuploidy and 1031 
the actual number of those observed in our dataset. 1032 
Figure 3.  Complex sex chromosome mosaicism in an XXY male. a) shows the chromosomal sex 1033 
and mitochondria complement of the parents and XXY progeny. b) was used to identify the sex 1034 
chromosome aneuploidy (two X chromosomes and Y present) and as evidence of mosaicism for 1035 
presence and absence of Y chromosome (low Y intensity). c) provides evidence of mosaicism for 1036 
the X chromosome and identifies the paternal origin (129X1/SvJ) of the chromosome lost in 1037 
some cells. d) The sex chromosome complement of the two types of cells present in this male 1038 
are shown. Panels b and c were used also to estimate the fraction of each type of cells. (blue 1039 
points denote C57BL/6J genotype calls, red points 129s1/SvImJ genotype calls. Panels a, c, d).   1040 
Figure 4.  Segmental chromosome Y duplications in laboratory strains.  a) Normalized median Y 1041 
chromosome intensity in selected samples with C3H/He, DBA/1 and C57BL/6 Y chromosomes. 1042 
Samples with a C3H/HeJ Y chromosome are shown in orange while samples with any other 1043 
C3H/He Y chromosome are shown in different shades of blue.  b) Spatial distribution of 1044 
normalized intensity at SNPs in the proximal end of the Y chromosome in the same C3H/He 1045 
samples shown in the a panel.  The range of intensities in samples with a C3H/HeJ Y 1046 
chromosome are shown in orange while samples with any other type of C3H/He Y chromosome 1047 
are shown in blue.  Duplicated region is shown in red and transition regions with uncertain copy 1048 
number are shown in pink.  The bottom of the figure shows the location of the MiniMUGA 1049 
markers and genes.  1050 
Figure 5.  Pairwise number of informative calls in classical inbred strains.  Strains are ordered by 1051 
similarity and colors represent the number of informative SNPs based on the consensus 1052 
genotypes. Only homozygous base calls, at tier 1 and 2 markers, on the autosomes, X, and PAR 1053 
are included. 1054 
Figure 6.  Haplotype diversity of the mitochondria (a) and chromosome Y (b). The trees are built 1055 
based on the variation present in MiniMUGA and may not represent the real phylogenetic 1056 
relationships. Colors denote the subspecies-specific origin of the haplotype in question: shades 1057 
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of blue represent M. m. domesticus haplotypes; shades of red represent M. m. musculus 1058 
haplotypes; shades of green represent M. m. castaneus haplotypes. 1059 
Figure 7.  Percent of the genome covered by MiniMUGA in RCCs.  The 78 RCCs are shown in 1060 
ascending order independently for each one of the six analyses. Coverage was based on the 1061 
linkage distance to the nearest informative marker in a given RCC cross. 1062 
Figure 8.  Detection of genetic constructs. For each construct, samples are classified as negative 1063 
controls (left), experimental (center) and positive controls (right).  The dot color denotes 1064 
whether the sample is determined to be negative (blue), positive (red), or questionable (grey) 1065 
for the respective construct. For each construct, the grey horizontal lines represent the 1066 
thresholds for positive and negative results. Note for each construct, the Y-axis scale is 1067 
different. 1068 
Figure 9.  Background Analysis Report for the sample B6.Cg-Cdkn2atm3.1Nesh Tyrc-2J Hrhr/Mmnc 1069 
(named MMRRC_UNC_F38673). The genotype of this sample is of excellent quality. It is a close 1070 
to inbred female that is a congenic mouse with C57BL/6J as a primary background, and with 1071 
multiple regions of a 129S background. This sample is positive for a luciferase-family construct 1072 
and negative for 16 other constructs. 1073 
Figure 10.  Age and breeding history of mouse samples with C57BL/6J background. a) Inbred 1074 
Baff-/- male in C57BL/6J background.  b) Inbred transgenic and IFNgR1 female in C57BL/6J 1075 
background.  c) Inbred C57BL/6J male. Red bars denote the ancestral allele for diagnostic SNPs 1076 
fixed at E3. Pink bars denote ancestral alleles for diagnostic SNPs fixed at the start of the CC. 1077 
Light blue bars denote diagnostic alleles at diagnostic SNPs fixed at E3. Lighter blue bars denote 1078 
diagnostic alleles at diagnostic SNPs fixed at start of CC. Grey bars denote ancestral alleles at 1079 
post-CC diagnostic SNPs. Dark blue bars denote diagnostic alleles at post-CC diagnostic SNPs. 1080 
Split bars denote heterozygous SNPs in a sample.  1081 
 1082 
  1083 
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SUPPLEMENTARY MATERIAL LEGENDS 1084 
Supplementary Table 1. Samples included in this study. The table provides the following 1085 
information: 1086 
Serial ID. 1087 
Sample name: name provided by the investigator. 1088 
Type: inbred, F1, cell line, cross or unclassified. 1089 
Content Type: initial or Final. 1090 
Consensus strain: if a sample was used to build the consensus genotypes of one 241 inbred 1091 
strain, that strain name is listed, if that sample was not used then zero. 1092 
Chromosomal sex marker selection: TRUE for samples used in selecting sex informative 1093 
markers. FALSE for samples not used. 1094 
Chromosomal sex: XX, XY, X0, XXY or XX*.  The latter group are XX samples misclassified as XO. 1095 
Replicate: TRUE for technical replicates genotyped more than once. FALSE for samples 1096 
genotyped only once. 1097 
Replicate name: An unambiguous name for that group of replicate samples. 1098 
X chromosome intensity: median normalized intensity of chromosome X sex-informative 1099 
markers. 1100 
Y chromosome intensity: median normalized intensity of chromosome Y sex-informative 1101 
markers. 1102 
Median autosomal intensity: median intensity of autosomal markers (i.e., normalization factor) 1103 
H calls: Number of heterozygous calls for tier 1 and 2 markers (see below) in the autosomes and 1104 
chromosome X. 1105 
H call on chromosome X: Number of heterozygous calls for tier 1 and 2 markers (see below) on 1106 
chromosome X. 1107 
Autosomal N calls: Number of no calls for tier 1 and 2 markers (see below) in the autosomes. 1108 
N calls on chromosome X: Number of no calls for tier 1 and 2 markers (see below) in the X 1109 
chromosome.  1110 
ks_stat: Kolmogorov-Smirnov goodness of fit test statistic of the sample’s autosomal intensities 1111 
against the autosomal intensity distribution of 200 random samples 1112 
pd_stat: Pearson's chi-squared test statistic of the sample’s autosomal intensities against the 1113 
autosomal intensity distribution of 200 random samples. 1114 
BlastR: Sum of the autosome-normalized xraw intensity at 6 markers used to declare the 1115 
presence or absence of the construct Blasticidin resistance. 1116 
Cas9: Sum of the autosome-normalized xraw intensity at 7 markers used to declare the 1117 
presence or absence of the construct Cas9 1118 
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Cre: Sum of the autosome-normalized xraw intensity at 15 markers used to declare the 1119 
presence or absence of the construct Cre recombinase 1120 
DT: Sum of the autosome-normalized xraw intensity at 11 markers used to declare the presence 1121 
or absence of the construct Diptheria toxin 1122 
IRES: Sum of the autosome-normalized xraw intensity at 6 markers used to declare the 1123 
presence or absence of the construct Internal Ribosome Entry Site 1124 
Luc: Sum of the autosome-normalized xraw intensity at 10 markers used to declare the 1125 
presence or absence of the construct Luciferase 1126 
SV40: Sum of the autosome-normalized xraw intensity at 18 markers used to declare the 1127 
presence or absence of the construct SV40 large T antigen 1128 
bpA: Sum of the autosome-normalized xraw intensity at 8 markers used to declare the presence 1129 
or absence of the construct Bovine growth hormone poly A signal sequence 1130 
chlor: Sum of the autosome-normalized xraw intensity at 9 markers used to declare the 1131 
presence or absence of the construct Chloramphenicol acetyltransferase 1132 
g FP: Sum of autosome-normalized xraw intensity at 19 markers used to declare the presence 1133 
or absence of the construct "Greenish" Fluorescent Protein (EGFP, EYFP, ECFP) 1134 
hCMV a: Sum of the autosome-normalized xraw intensity at 6 markers used to declare the 1135 
presence or absence of the construct hCMV enhancer version a. 1136 
hCMV b: Sum of the autosome-normalized xraw intensity at 11 markers used to declare the 1137 
presence or absence of the construct hCMV enhancer version b 1138 
hTK pr: Sum of the autosome-normalized xraw intensity at 2 markers used to declare the 1139 
presence or absence of the construct Herpesvirus TK promoter 1140 
iCre: Sum of the autosome-normalized xraw intensity at 8 markers used to declare the presence 1141 
or absence of the construct iCre recombinase 1142 
r FP:  Sum of the autosome-normalized xraw intensity at 5 markers used to declare the 1143 
presence or absence of the construct "Reddish" fluorescent protein (tdTomato, mCherry) 1144 
rtTA: Sum of the autosome-normalized xraw intensity at 8 markers used to declare the 1145 
presence or absence of the construct Reverse improved tetracycline-controlled transactivator 1146 
tTA: Sum of the autosome-normalized xraw intensity at 14 markers used to declare the 1147 
presence or absence of the construct Tetracycline repressor protein 1148 
 1149 
  1150 
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Supplementary Table 2. Marker annotation.  The table contains the following information: 1151 
1) Marker name. 1152 
2) Chromosome. The following types are allowed: 1-19, for the autosomes; X and Y for the sex 1153 
chromosomes; PAR, for markers on the pseudoautosomal region; MT, for the mitochondria and 1154 
0, for genetic constructs. 1155 
3) Position in bases in build 38. 1156 
4) Strand.  +, indicating the probe sequence is found in the 5' to 3' order (on the forward strand) 1157 
in the reference genome immediately preceding the variant.  -, indicating that the reverse 1158 
complement of the probe sequence is found in the 5' to 3' order (on the forward strand) in the 1159 
reference genome, immediately following the variant and NA, when not available. 1160 
5-6) Sequences A and B.  Sequence A for one bead probes is the sequence of the marker probe 1161 
without the SNP and for two bead probes, the sequence of the marker probe including the SNP. 1162 
Sequence B: for one bead probes, not applicable; for two bead probes, the alternative 1163 
sequence of the marker probe including the SNP. 1164 
7-8) Reference Allele and Alternate allele. Columns denoting the genotype call for the reference 1165 
and alternative alleles 1166 
9) Tier. For biallelic SNP markers, tier was assigned based on observed genotype call types 1167 
(homozygous reference, homozygous alternate, or heterozygous) at each marker across a set of 1168 
3,878 samples used for array QC and validation. Tier 1 markers were those for which we 1169 
observe all three call types. Tier 2 markers were those for which we observe two of the three 1170 
call types. Tier 3 markers were those for which we observe only one call type. Tier 4 markers 1171 
were those markers for which we observe no calls (N) in every sample.  For construct markers, 1172 
tier is assigned based on the capability of a marker to detect a given construct. Informative tier 1173 
makers are those for which the marker has been validated to test for the presence or absence 1174 
of a given construct based on intensity. Partially informative tier makers were those for that 1175 
could potentially be used to test for the presence or absence of a given construct based on 1176 
intensity.  Those markers which have not been tested were assigned the tier “Not tested”. 1177 
10) rsID. 1178 
11) Diagnostic.  Name of the construct, substrain or strain group that the maker is diagnostic 1179 
for. In all other cases is empty. 1180 
12) Diagnostic type. Substrain, strain group or construct.  1181 
13) Diagnostic information: Abbreviated name of the construct, name of substrain or list of 1182 
substrains in which we observed the diagnostic allele. In all other cases is empty. 1183 
14) Partial diagnostic: 1, for diagnostic alleles that are not fixed. 0, in all other cases. 1184 
15) Diagnostic allele. Whether the reference or alternative allele is the diagnostic  1185 
16) Positive threshold. Threshold value to declare the presence of a given construct 1186 
17) Negative threshold. Threshold value to declare the absence of a given construct. 1187 
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18) Uniqueness measured using Bowtie. 1188 
19) X chromosome markers used to determine the presence and number of X chromosomes. 1, 1189 
chromosome X markers used in sex chromosome determination. 0, in all other cases. 1190 
20) Y chromosomes markers used to determine the presence of a Y chromosome. 1, 1191 
chromosome Y markers used in sex chromosome determination. 0, in all other cases. 1192 
21) Flags. SPIKE, markers added in the final iteration of the array. Empty in all other cases.  1193 
22) Diagnostic Birth. The population where a diagnostic allele was first seen (E2, E3, E4 in the 1194 
BxD, Pre-Cc, CC or Post-CC in the Collaborative Cross) 1195 
23) Diagnostic Fixation. The population where a diagnostic allele is inferred to be fixed (E3, CC 1196 
or segregating) 1197 
Supplementary Table 3. List of inbred strains with consensus genotypes grouped into four 1198 
classes: classical, wild-derived, CC and BXD. 1199 
Supplementary Table 4.  Examples of the rules for consensus genotypes calls. *, denotes the 1200 
diagnostic allele.  1201 
Supplementary Table 5.  Consensus genotypes.   1202 
Supplementary Table 6.  Aneuploid, mosaic and misclassified samples.   1203 
Supplementary Table 7.  Number of samples with N and not N genotype calls in the autosomes 1204 
and X chromosome of sample TL9348. 1205 
Supplementary Table 8.  Construct probe design annotation   1206 
 1207 
 1208 
Supplementary Figure 1. Sex effect on normalized intensity for markers on chromosome X.  The 1209 
left figure represents 269 markers considered informative based on the lack of overlap between 1210 
the distribution of intensities in males (blue) and females (red).  The right represents 426 1211 
makers that are not considered sex informative. 1212 
Supplementary Figure 2. Alignments of validated construct markers. For each construct the file 1213 
provides a short summary, the alignment of the working probes, the target DNA and protein 1214 
sequences. The alignment of forward (black) and reverse (blue) probes is shown with the 1215 
nucleotide used for “genotyping” (A) shown in red background for forward probes and in blue 1216 
(T) for reverse probes.  Mismatches are shown in purple background.  1217 
Supplementary Figure 3. Examples of normal and abnormal intensity distributions.  Intensity 1218 
distributions for six samples with low pd_stat and six samples with high pd_stat on the 1219 
autosomes and chromosome X.  Colored histogram bars are the intensity values distribution on 1220 
the corresponding chromosome. Colored lines are the kernel density estimates for these data. 1221 
Black lines are an attempt to fit the actual data to a normal curve.  1222 
Supplementary Figure 4.  The distribution of pd_stat values in the 6,899 samples is shown on 1223 
the y axis. The x axis shows the ks_stat for better contrast.  Threshold determination for 1224 
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chromosomal sex using pd_stat. Samples in yellow were incorrectly identified as XO but are in 1225 
fact XX (aka XX*, Supplementary Tables 1 and 4). Samples in green are from mouse species 1226 
other than Mus musculus. Samples in blue are labeled Aneuploid by our algorithm. We 1227 
manually established a threshold to capture all the misclassified samples and samples from 1228 
other species.  1229 
Supplementary Figure 5. Chromosome Y duplications.  Spatial distribution of normalized 1230 
intensity at SNPs in the proximal end of the Y chromosome in C3H/He, DBA/1 and C57BL/6 1231 
samples.  The range of intensities are shown in orange in cases where we had multiple samples 1232 
with the duplication while samples with normal Y chromosome are shown in blue.  Duplicated 1233 
regions are shown in red and transition regions with uncertain copy number are shown in pink.  1234 
The bottom of the figure shows the location of the MiniMUGA markers and genes. 1235 
Supplementary Figure 6.  Intensities of all construct markers present in MiniMUGA.  Markers 1236 
are grouped according to construct.  The color denotes whether the sample is deemed to be a 1237 
negative control (blue), positive control (red), or experimental (dark brown) for the respective 1238 
construct.  Markers with asterisks were excluded in the construct analysis. 1239 
Supplementary Figure 7.  Inbreeding thresholds. The figure shows in red the distribution of 1240 
observed H calls in 385 samples representing 85 classical inbred strains. It also shows in blue 1241 
the distribution of predicted number of H calls in 3,655 F1 hybrids using the consensus 1242 
genotypes from 86 classical inbred strains. Tier 1 and 2 markers on the autosomes, X 1243 
chromosomes and PAR were used. Thresholds for inbred, close to inbred and outbred are 1244 
shown as vertical bars. 1245 
Supplementary Figure 8.  MiniMUGA Background Analysis Report for the following four female 1246 
cell lines: C2Cl2, GPG C3-Tag-T1-Luc, MLE12, and C57BL/6J. 1247 
Supplementary Figure 9.  De novo X chromosome duplication. The range of intensities for 1248 
females and males are shown in pink and blue, respectively. The sample with the duplication is 1249 
shown as black line.  Genotypes for the parental CC strains and the test sample are shown at 1250 
the bottom as well as the first marker included in the duplication (asterisk) and the extent. 1251 
Supplementary Figure 10.  Age and breeding history of four mouse samples from the B6.129-1252 
Nox4tm1kkrJ congenic line maintained through breeding at UNC. Green triangles note the 1253 
position of the generate allele. Red bars denote the ancestral allele for diagnostic SNPs fixed at 1254 
E3. Pink bars denote ancestral alleles for diagnostic SNPs fixed at the start of the CC. Light blue 1255 
bars denote diagnostic alleles at diagnostic SNPs fixed at E3. Lighter blue bars denote diagnostic 1256 
alleles at diagnostic SNPs fixed at start of CC. Grey bars denote ancestral alleles at post-CC 1257 
diagnostic SNPs. Dark blue bars denote diagnostic alleles at post-cc diagnostic SNPs. Split bars 1258 
denote heterozygous SNPs in a sample. 1259 
 1260 
 1261 
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Parentals
XO and XXY
Progeny
Parental Origin
Number
Pat Mat Mat Pat Pat ?? Pat Pat Pat ??
6 1 0 6 2 1 4 0 2 0
X X
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Informative
Calls
Number of
Comparisons
Percentage of
Comparisons
0 2 0.05
1-9 4 0.11
10-19 1 0.03
20-39 12 0.33
40-79 26 0.71
80-159 48 1.31
160-319 68 1.86
320-639 80 2.19
640-1279 61 1.67
1280-2559 1015 27.77
2560-3396 2338 63.97
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MiniMUGA Background Analysis v0008
Sample ID MMRRC_UNC_F38673
Neogen ID US7600
Summary
The genotype of this sample is of excellent quality. It is female and close to inbred, and
likely a mix of multiple C57BL/6 substrains and (129S1/SvImJ and/or 129S2/SvHsd
and/or 129S2/SvPasOrlRj and/or 129S4/SvJaeJ and/or 129S6/SvEvTac). Clustering of
unexplained markers is evidence of an additional background strain. 
Diagnostic SNPs indicate the presence of the background strain groups C57BL/6 and the
substrains C57BL/6J. 
The sample contains the following genetic constructs: Luciferase
Genotyping Quality
Excellent (18 N calls) 
All reported results are dependent on genotyping quality.
Chromosomal Sex XX
Inbreeding Estimate Close to Inbred (200 H calls at autosomal, X, and PAR chromosome markers)
Inbreeding and
Genotyping Quality
(Plot)
Constructs Detected
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Primary Background 
(Autosomes, 
X Chromosome)
Strain Total Consistent Inconsistent Heterozygous Excluded
multiple C57BL/6
substrains
9721 9087
(97.9%)
50 (0.5%) 148 (1.6%) 436
Secondary Background 
(Autosomes, 
X Chromosome)
Strain Total Explained Unexplained Excluded
129S1/SvImJ and/or
129S2/SvHsd and/or
129S2/SvPasOrlRj and/or
129S4/SvJaeJ and/or
129S6/SvEvTac
198 
193 Clustered
182 (2.0%) 
181 Clustered
16 (0.2%) 
7 Clustered
0 (0.0%) 
Background Ideogram
Backgrounds Detected 
(Diagnostic Alleles)
  Diagnostic Alleles Observed
Substrain Homozygous Heterozygous Potential % Observed
C57BL/6J 77 45 156 78.2%
Strain Group Homozygous Heterozygous Potential % Observed
C57BL/6 
(B6N-Tyr/BrdCrCrl, C57BL/6J,
C57BL/6JBomTac,
C57BL/6JEiJ,
C57BL/6JOlaHsd,
C57BL/6NCrl, C57BL/6NHsd,
C57BL/6NJ, C57BL/6NRj,
C57BL/6NTac)
6 1 21 33.3%
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Content Chromosomal sex Inbred F1 CC Cross Unclassified Cell lines Total
XX 138 131 305 1383 817 87 2861
XY 265 41 181 1236 907 74 2704
XO 0 1 3 11 8 9 32
XXY 0 1 1 2 3 0 7
5604
XX 41 59 40 580 21 4 745
XY 153 13 7 248 112 10 543
XO 0 1 0 2 0 0 3
XXY 0 0 0 4 0 0 4
1295
Total 597 247 537 3466 1868 184 6899
Initial
SubTotal
Final
SubTotal
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Background Strain GroupDiagnostic Type Full Partial
129P2/OlaHsd 129P substrain 25 0
129P3/J 129P substrain 54 0
129S1/SvImJ 129S substrain 82 13
129S2/SvHsd 129S substrain 7 1
129S2/SvPasOrlRj 129S substrain 36 0
129S4/SvJaeJ 129S substrain 45 0
129S5/SvEvBrd 129S substrain 12 0
129S6/SvEvTac 129S substrain 41 0
129T2/SvEmsJ 129T substrain 38 0
129X1/SvJ 129X substrain 39 0
A/J A substrain 58 7
A/JCr A substrain 53 0
A/JOlaHsd A substrain 38 0
BALB/cAnNCrl BALB /c substrain 36 2
BALB/cAnNHsd BALB /c substrain 109 4
BALB/cByJ BALB /c substrain 3 4
BALB/cByJRj BALB /c substrain 19 0
BALB/cJ BALB /c substrain 103 3
BALB/cJBomTac BALB /c substrain 47 0
C3H/HeJ C3H/He substrain 166 2
C3H/HeNCrl C3H/He substrain 39 0
C3H/HeNHsd C3H/He substrain 39 1
C3H/HeNRj C3H/He substrain 42 0
C3H/HeNTac C3H/He substrain 45 14
C57BL/6J C57BL/6 substrain 136 20
C57BL/6JBomTac C57BL/6 substrain 41 2
C57BL/6JOlaHsd C57BL/6 substrain 43 0
C57BL/6NJ C57BL/6 substrain 37 7
C57BL/6NRj C57BL/6 substrain 20 0
B6N-Tyr<c-Brd>/BrdCrCrl C57BL/6 substrain 21 10
DBA/1J DBA/1 substrain 70 0
DBA/1LacJ DBA/1 substrain 77 2
DBA/1OlaHsd DBA/2 substrain 32 0
DBA/2J DBA/2 substrain 112 0
DBA/2JOlaHsd DBA/2 substrain 39 0
DBA/2JRj DBA/2 substrain 30 0
DBA/2NCrl DBA/2 substrain 85 14
DBA/2NTac DBA/2 substrain 36 10
FVB/NCrl FVB substrain 47 0
FVB/NHsd FVB substrain 39 1
FVB/NJ FVB substrain 72 7
FVB/NRj FVB substrain 47 0
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FVB/NTac FVB substrain 37 0
NOD/MrkTac NOD substrain 33 0
NOD/ShiLtJ NOD substrain 51 3
2281 127
129S 129S strain group 17 0
A A strain group 57 0
BALB/c BALB/c strain group 125 0
C3H/He C3H/He strain group 45 0
C57BL/10 C57BL/10 strain group 291 0
C57BL/6 C57BL/6 strain group 19 0
DBA/1 DBA/1 strain group 5 0
DBA/2 DBA/2 strain group 62 0
FVB/N FVB/N strain group 2 0
NZO NZO strain group 12 0
635 0
2916 127
Subtotal
Subtotal
TOTAL
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WGS
Sanger
UNC
Sanger
UNC
UNC
UNC
Sanger
UNC
UNC
UNC
Sanger
UNC
UNC
UNC
UNC
UNC
UNC
Sanger
UNC
Sanger
UNC
UNC
UNC
UNC
Reference
UNC
UNC
Sanger
UNC
UNC
Sanger
UNC
UNC
Sanger
UNC
UNC
UNC
UNC
UNC
UNC
Sanger
UNC
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UNC
UNC
Sanger
Abraham
Sanger
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Name Abreviation
"Greenish" Fluorescent Protein (EGFP, EYFP, ECFP) g_FP
SV40 large T antigen SV40
Cre recombinase Cre
Tetracycline repressor protein tTA
Diptheria toxin DTA
Human CMV enhancer version b hCMV_b
Luciferase and firefly luciferase Luc
Chloramphenicol acetyltransferase chloR
Bovine growth hormone poly A signal sequence bpA
iCre recombinase iCre
Reverse improved tetracycline-controlled transactivator rtTA
Caspase 9 cas9
Blasticidin resistance BlastR
Internal Ribosome Entry Site IRES
hCMV enhancer version a hCMV_a
"Reddish" fluorescent protein (tdTomato, mCherry) r_FP
Herpesvirus TK promoter hTK_pr
Total
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# of probes # of distinct probes
19 19
18 18
16 12
14 14
11 11
10 7
10 10
9 9
8 4
8 8
8 4
7 7
6 4
6 6
5 4
6 6
2 2
163 145
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A)
Epoch Full Partial Full Partial C57BL/6 DBA/2 Other
I 0 0 4 0 2 24 1 0 0
II 72 0 68 0 4 (2) 0 0 0 1*
III 34 0 16 0 0 0 0 0 0
IV 30 20 24 0 0 0 0 0 0
B)
Full Partial Full Partial Full Partial Full Partial
PreCC 47 0 116 7 75 6 34 0
During CC 8 3 16 7 2 4 2 0
PostCC 0 2 0 3 0 1 0 1
NOD/ShiLtJ
C57BL/6J DBA/2J C57BL/6 
group
DBA/2J 
group
A/J C57BL/6J 129S1/SvImJ
.CC-BY-NC 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.03.12.989400doi: bioRxiv preprint 
